End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
163.2 SAR | -1.33% | -3.89% | -5.01% |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
Sales 2024 * | 3.23B 860M | Sales 2025 * | 3.58B 956M | Capitalization | 15.94B 4.25B |
---|---|---|---|---|---|
Net income 2024 * | 426M 114M | Net income 2025 * | 505M 135M | EV / Sales 2024 * | 5.46 x |
Net Debt 2024 * | 1.67B 445M | Net Debt 2025 * | 1.67B 446M | EV / Sales 2025 * | 4.92 x |
P/E ratio 2024 * |
41.3
x | P/E ratio 2025 * |
30.8
x | Employees | - |
Yield 2024 * |
1.41% | Yield 2025 * |
1.85% | Free-Float | 41.94% |
1 day | -1.33% | ||
1 week | -3.89% | ||
Current month | -2.51% | ||
1 month | -7.38% | ||
3 months | -5.66% | ||
6 months | +17.24% | ||
Current year | -5.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Tarek Al-Kasabi
CHM | Chairman | 72 | 93-12-31 |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 117 M€ | +0.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 163.2 | -1.33% | 68,884 |
24-04-24 | 165.4 | -0.48% | 48,674 |
24-04-23 | 166.2 | -1.19% | 72,665 |
24-04-22 | 168.2 | -0.83% | 80,306 |
24-04-21 | 169.6 | -0.12% | 49,509 |
End-of-day quote Saudi Arabian S.E., April 24, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.01% | 4.31B | |
-22.63% | 15.4B | |
+3.60% | 12.12B | |
+3.65% | 11.43B | |
+11.92% | 10.84B | |
+24.00% | 8.29B | |
-0.40% | 7.78B | |
+20.75% | 7.33B | |
+4.53% | 6.75B | |
+49.97% | 4.65B |
- Stock Market
- Equities
- 4004 Stock